Better pain relief
Arthritis patients who have problems with the side effects of current drugs were offered new hope this week, as two new treatments were announced by different companies. Health Canada has approved “Celebrex” for both acute and chronic use in the relief of the signs and symptoms of osteoarthritis (OA) and rheumatoid arthritis (RA) in adults.
Celebrex received priority review from Health Canada and will be available by prescription in Canada by April 27, 1999. Since its introduction in the United States in January, Celebrex has become one of the fastest selling new drugs in history.
Clinical trials showed the drug as comparable to the maximum prescription-strength Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) naproxen and ibuprofen in treating arthritis pain and inflammation. The new drug’s extra benefit is that produces significantly fewer upper gastrointestinal (GI) ulcers than traditional arthritis medications.